NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $93 | -30.6% | 2,236 | 0.0% | 0.00% | -40.0% |
| Q1 2023 | $134 | -18.3% | 2,236 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $164 | -99.9% | 2,236 | +0.8% | 0.01% | 0.0% |
| Q3 2022 | $169,000 | +11.2% | 2,218 | +1.4% | 0.01% | 0.0% |
| Q2 2022 | $152,000 | +24.6% | 2,187 | +48.0% | 0.01% | +50.0% |
| Q1 2022 | $122,000 | -39.9% | 1,478 | -45.5% | 0.00% | -42.9% |
| Q4 2021 | $203,000 | -43.8% | 2,710 | -12.9% | 0.01% | -46.2% |
| Q3 2021 | $361,000 | -50.4% | 3,110 | -5.2% | 0.01% | -48.0% |
| Q2 2021 | $728,000 | +217.9% | 3,281 | +89.2% | 0.02% | +177.8% |
| Q1 2021 | $229,000 | -23.7% | 1,734 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $300,000 | +55.4% | 1,734 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $193,000 | +87.4% | 1,734 | 0.0% | 0.01% | +80.0% |
| Q2 2020 | $103,000 | – | 1,734 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |